- Home
- SXTP vs MTNB Comparison
SXTP vs MTNB Comparison
Compare SXTP & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTP
- MTNB
- Stock Information
- Founded
- SXTP 2010
- MTNB 2013
- Country
- SXTP United States
- MTNB United States
- Employees
- SXTP N/A
- MTNB N/A
- Industry
- SXTP Biotechnology: Pharmaceutical Preparations
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- SXTP Health Care
- MTNB Health Care
- Exchange
- SXTP Nasdaq
- MTNB Nasdaq
- Market Cap
- SXTP 2.7M
- MTNB 3.1M
- IPO Year
- SXTP 2023
- MTNB N/A
- Fundamental
- Price
- SXTP $2.95
- MTNB $0.67
- Analyst Decision
- SXTP Hold
- MTNB Hold
- Analyst Count
- SXTP 1
- MTNB 1
- Target Price
- SXTP N/A
- MTNB N/A
- AVG Volume (30 Days)
- SXTP 4.8M
- MTNB 32.8K
- Earning Date
- SXTP 05-14-2025
- MTNB 04-15-2025
- Dividend Yield
- SXTP N/A
- MTNB N/A
- EPS Growth
- SXTP N/A
- MTNB N/A
- EPS
- SXTP N/A
- MTNB N/A
- Revenue
- SXTP $681,345.00
- MTNB N/A
- Revenue This Year
- SXTP $95.50
- MTNB N/A
- Revenue Next Year
- SXTP $80.78
- MTNB N/A
- P/E Ratio
- SXTP N/A
- MTNB N/A
- Revenue Growth
- SXTP 168.70
- MTNB N/A
- 52 Week Low
- SXTP $1.41
- MTNB $0.48
- 52 Week High
- SXTP $36.00
- MTNB $9.70
- Technical
- Relative Strength Index (RSI)
- SXTP 56.45
- MTNB 64.44
- Support Level
- SXTP $2.48
- MTNB $0.54
- Resistance Level
- SXTP $3.45
- MTNB $0.60
- Average True Range (ATR)
- SXTP 0.70
- MTNB 0.05
- MACD
- SXTP 0.02
- MTNB 0.01
- Stochastic Oscillator
- SXTP 47.63
- MTNB 100.00
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.